Full Text
The Full Text of this article is available as a PDF (39.4 KB).
References
- 1. Plutzky J, Viberti G, Haffner S: Atherosclerosis in type 2 diabetes mellitus and insulin resistance: Mechanistic links and therapeutic targets. J Diabetes Complications 2002; 16: 401–415 [DOI] [PubMed] [Google Scholar]
- 2. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. J Am Med Assoc 2002; 287: 2570–2581 [DOI] [PubMed] [Google Scholar]
- 3. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1143 [DOI] [PubMed] [Google Scholar]
- 4. Fernandez‐Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278–301 [DOI] [PubMed] [Google Scholar]
- 5. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191–203 [DOI] [PubMed] [Google Scholar]
- 6. Schmitz G, Kaminski WE: ATP‐binding cassette (ABC) transporters in atherosclerosis. Curr Atheroscler Rep 2002; 4: 243–251 [DOI] [PubMed] [Google Scholar]
- 7. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002; 90: 251–262 [PubMed] [Google Scholar]
- 8. Plutzky J: PPARs as therapeutic targets: Reverse cardiology? Science 2003; 302: 406–407 [DOI] [PubMed] [Google Scholar]
- 9. Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARs: From orphan receptors to drug discovery. J Med Chem 2000; 43: 527–550 [DOI] [PubMed] [Google Scholar]
- 10. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998; 98: 2088–2093 [DOI] [PubMed] [Google Scholar]
- 11. Henry RR: Thiazolidinediones. Endocrinol Metab Clin North Am 1997; 26: 553–573 [DOI] [PubMed] [Google Scholar]
- 12. Choudhury AI, Chahal S, Bell AR, Tomlinson SR, Roberts RA, Salter AM, Bell DR: Species differences in peroxisome proliferation: Mechanisms and relevance. Mutat Res 2000; 448: 201–212 [DOI] [PubMed] [Google Scholar]
- 13. Beckman J, Raji A, Plutzky J: Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: Issues and opportunities. Curr Opin Cardiol 2003; 18: 479–485 [DOI] [PubMed] [Google Scholar]
- 14. Glass CK, Witztum JL: Atherosclerosis: The road ahead. Cell 2001; 104: 503–516 [DOI] [PubMed] [Google Scholar]
- 15. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R: Thiazolidinedione use, fluid retention, and congestive heart failure: A consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation 2003; 108: 2941–2948 [DOI] [PubMed] [Google Scholar]